ctDNA Assessment of EGFR Mutation Status in Chinese Patients with Advanced Non-Small-Cell Lung Cancer in Read World Setting

被引：1
|
作者：
Zhang, S. [1 ]
Zhu, L. [1 ]
Chen, X. [1 ]
Chen, E. [2 ]
Li, Y. [3 ]
Fang, H. [4 ]
Feng, Y. [5 ]
Qiong, Z. [6 ]
He, H. [7 ]
Ma, S. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Resp, Hangzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp, Wenzhou, Peoples R China
[4] Zhejiang Xiaoshan Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[5] Hangzhou Normal Univ, Affiliated Hosp, Dept Resp, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[7] Quzhou Peoples Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
ctDNA; ARMS; EGFR;
D O I：
10.1016/j.jtho.2017.09.1472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-031
引用
收藏
页码：S2212 / S2212
页数：1
相关论文
共 50 条
  • [1] ctDNA assessment of EGFR mutation status in Chinese patients with advanced non-small cell lung cancer in real-world setting
    Zhang, Shirong
    Zhu, Lucheng
    Chen, Xueqin
    Zhang, Xiaochen
    Chen, Enguo
    Fang, Hongming
    Feng, Yuejuan
    Li, Yuping
    Wang, Xi
    Jiang, Zhongyu
    Wang, Yina
    Zhang, Zhihao
    He, Huijuan
    Ma, Shenglin
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : 4169 - +
  • [2] Customized Chemotherapy on the Basis of EGFR Mutation Status for Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Kunimasa, K.
    Katakami, N.
    Masago, K.
    Yoshioka, H.
    Tomii, K.
    Kaneda, T.
    Hirabayashi, M.
    Morizane, T.
    Fujita, S.
    Mio, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S280 - S280
  • [3] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
  • [4] Chemotherapy influence EGFR mutation status for Chinese patients with regionally advanced non-small cell lung cancer
    Wang, J.
    Chen, K.
    Bai, H.
    Zhao, J.
    Wang, Z.
    Zhuo, M.
    An, T.
    Duan, J.
    Yang, L.
    Wu, M.
    Guo, Q.
    Liu, X.
    Wang, S.
    Wang, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer
    Zhang, XT
    Li, LY
    Mu, XL
    Cui, QC
    Chang, XY
    Song, W
    Wang, SL
    Wang, MZ
    Zhong, W
    Zhang, L
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (08) : 1334 - 1342
  • [6] The impact of EGFR mutation and smoking status on non-small-cell lung cancer patients treated with geftinib
    Toyooka, Shinichi
    Takano, Toshimi
    Kosaka, Takayuki
    Ichihara, Shuji
    Fujiwara, Yoshiro
    Hotta, Katsuyuki
    Soh, Junichi
    Kiura, Katsuyuki
    Yatabe, Yasushi
    Ohe, Yuichiro
    Mitsudomi, Tetsuya
    Date, Hiroshi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S324 - S324
  • [7] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [8] EGFR mutation analysis in non-small-cell lung cancer
    Tapia, C.
    Savic, S.
    Bihl, M.
    Rufle, A.
    Zlobec, I.
    Terracciano, L.
    Bubendorf, L.
    [J]. PATHOLOGE, 2009, 30 (05): : 384 - 392
  • [9] Gefitinib for Chinese patients with advanced non-small-cell lung cancer
    Xiaotong, Z
    Longyun, L
    Xinlin, MU
    [J]. LUNG CANCER, 2004, 45 : S79 - S79
  • [10] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Mraihi, Zohra
    Ben Amar, Jihen
    Bouacha, Hend
    Rammeh, Soumaya
    Hila, Lamia
    [J]. BMC PULMONARY MEDICINE, 2018, 18
12345